Komori
Governance4586Medrx Co.,Ltd.Pharmaceuticals

Notice Regarding the Application to Change Market Classification to the Tokyo Stock Exchange "Standard Market"

The Board of Directors resolved to apply to change the Company's listing market on the Tokyo Stock Exchange from the Growth Market to the Standard Market. The change is subject to approval by the Tokyo Stock Exchange.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Contents of this filing

Changes this time

The Board of Directors resolved to apply to change the market segment from the Tokyo Stock Exchange Growth Market to the Standard Market. The planned change date is 7 October 2026, subject to approval by the Tokyo Stock Exchange.

この書類は、機関設計や取締役会の構成そのものは述べていません。上に示したのは、この書類が述べている変更点です。

Contents of this filing
ItemDetails
Changes this timeThe Board of Directors resolved to apply to change the market segment from the Tokyo Stock Exchange Growth Market to the Standard Market. The planned change date is 7 October 2026, subject to approval by the Tokyo Stock Exchange.
Items this document does not state (7)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

After comprehensively considering the business environment and how the Company should engage in dialogue with the capital markets, the Company determined that selecting the Standard Market, as a market segment better suited to its management policies and business characteristics, would contribute to enhancing corporate value over the medium to long term.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Application to Change Market Classification to the Tokyo Stock Exchange "Standard Market" | Medrx Co.,Ltd. (4586) timely disclosure | Komori